Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexia Iasonos

Showing results (11-20 of 269) with videos related to

Pageof 27
Sort By:
Clinical Trials (London, England)|October 13, 2021
Commentary on Price and Scott: Complex innovative trial designAlexia Iasonos, John O'Quigley
Statistics in Medicine|December 7, 2016
Early phase dose finding methodologyAlexia Iasonos, John O'Quigley
Statistics in Medicine|February 9, 2016
Sequential monitoring of Phase I dose expansion cohortsAlexia Iasonos, John O'Quigley
Statistics in Biopharmaceutical Research|July 30, 2014
Bridging Solutions in Dose Finding ProblemsJohn O'Quigley, Alexia Iasonos
Contemporary Clinical Trials|July 10, 2016
Integrating the escalation and dose expansion studies into a unified Phase I clinical trialAlexia Iasonos, John O'Quigley
Statistics in Biopharmaceutical Research|August 13, 2016
Dose expansion cohorts in Phase I trialsAlexia Iasonos, John O'Quigley
Statistics in Medicine|November 17, 2022
"Improving the performance of Bayesian logistic regression model with overdose control in oncology dose-finding studies" by Hongtao Zhang, Alan Chiang, and Jixian WangAlexia Iasonos, Graham M Wheeler
Contemporary Clinical Trials|March 4, 2017
Measuring differential treatment benefit across marker specific subgroups: The choice of outcome scaleJaya M Satagopan, Alexia Iasonos
Clinical Trials (London, England)|August 13, 2011
Incorporating lower grade toxicity information into dose finding designsAlexia Iasonos, Sarah Zohar, John O'Quigley
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Clinical Trials in the Genomic EraErel Joffe, Alexia Iasonos, Anas Younes
Pageof 27

Showing results (11-20 of 269) with videos related to

Sort By:
Pageof 27
Clinical Trials (London, England)|October 13, 2021
Commentary on Price and Scott: Complex innovative trial designAlexia Iasonos, John O'Quigley
Statistics in Medicine|December 7, 2016
Early phase dose finding methodologyAlexia Iasonos, John O'Quigley
Statistics in Medicine|February 9, 2016
Sequential monitoring of Phase I dose expansion cohortsAlexia Iasonos, John O'Quigley
Statistics in Biopharmaceutical Research|July 30, 2014
Bridging Solutions in Dose Finding ProblemsJohn O'Quigley, Alexia Iasonos
Contemporary Clinical Trials|July 10, 2016
Integrating the escalation and dose expansion studies into a unified Phase I clinical trialAlexia Iasonos, John O'Quigley
Statistics in Biopharmaceutical Research|August 13, 2016
Dose expansion cohorts in Phase I trialsAlexia Iasonos, John O'Quigley
Statistics in Medicine|November 17, 2022
"Improving the performance of Bayesian logistic regression model with overdose control in oncology dose-finding studies" by Hongtao Zhang, Alan Chiang, and Jixian WangAlexia Iasonos, Graham M Wheeler
Contemporary Clinical Trials|March 4, 2017
Measuring differential treatment benefit across marker specific subgroups: The choice of outcome scaleJaya M Satagopan, Alexia Iasonos
Clinical Trials (London, England)|August 13, 2011
Incorporating lower grade toxicity information into dose finding designsAlexia Iasonos, Sarah Zohar, John O'Quigley
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Clinical Trials in the Genomic EraErel Joffe, Alexia Iasonos, Anas Younes
Pageof 27